Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.

Clinical trial NCT00174239 · TERMINATED

Trial details

NCT number: NCT00174239
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2004-07-01
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.